Stamford, CT -- (SBWIRE) -- 12/05/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: AT&T Inc. (NYSE:T), Thompson Creek Metals Company Inc (USA) (NYSE:TC), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), DETOUR GOLD CORP (OTCMKTS:DRGDF).
AT&T Inc. (NYSE:T) opened its last trade at the price of $34.34. Its closing price was $34.60 after losing -0.40% for the day. The company traded with the total volume of 27.22 million shares, while its average trading volume remained 22.60 million shares. The beta of this stock stands at 0.54. AT&T Inc. provides telecommunications services to consumers, businesses, and other providers in the United States and internationally. The company operates in three segments: Wireless, Wireline, and Other.
Has T Found The Bottom and Ready To Move Up? Find Out Here
Thompson Creek Metals Company Inc (USA) (NYSE:TC) percentage change plunged -9.69% to close at $2.33 with the total traded volume of 6.56 million shares, along with average volume of 1.26 million shares. The 52 week range of the stock remained $2.26 - $4.55, while its day lowest price was $2.26. The share price hit the day highest price of $2.62. Thompson Creek Metals Company Inc. engages in mining, milling, processing, and marketing of molybdenum products in the United States and Canada. The company operates in three segments: US Operations Molybdenum, Canadian Operations Molybdenum, and Copper-Gold (Development).
Has TC Found The Bottom And Ready To Gain Momentum? Find Out Here
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) traded on volume of 2.95 million shares in the last session against average volume of 554,326.00 shares. The company started its trading session with the price of $4.71 and closed at $4.62 by scoring -2.74%. Progenics Pharmaceuticals, Inc. engages in the research and development of biotechnology product candidates in the areas of oncology and therapeutics worldwide. The company offers RELISTOR (methylnaltrexone bromide), a subcutaneous injection for the treatment of opioid induced constipation (OIC) in patients with advanced illnesses.
Why Should Investors Buy PGNX After the Recent Fall? Just Go Here and Find Out
DETOUR GOLD CORP (OTCMKTS:DRGDF) started its last trading session with the price of $3.57 and closed at $3.61 by scoring +4.03%. The stock traded with total volume of 211,667.00 shares, while the average trading volume remained 89,387.00 shares. The beta value of this stock stands at 0.68. Day range for the stock was $3.35 - $3.64. Detour Gold Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada. The company primarily explores for gold. It primarily holds a 100% interest in the Detour Lake project covering an area of approximately 566 square kilometers in Northeastern Ontario.
Why Should Investors Buy DRGDF After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)